Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...
Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps. Dupixent ...
1don MSN
Looking inside a well-preserved Neanderthal nose to solve a mystery about our ancestors' faces
A long-standing debate in paleontology about whether the distinctive Neanderthal nose evolved purely for the cold weather may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback